Investment Summary

Wendel Group Invests In YesWeHack

On June 11, 2024, private equity firm Wendel Group invested in information technology company YesWeHack

Investment Highlights
  • This is Wendel Group’s 4th transaction in the Information Technology sector.
  • This is Wendel Group’s 10th transaction in France.

Investment Summary

Date 2024-06-11
Target YesWeHack
Sector Information Technology
Investor(s) Wendel Group
Deal Type Growth Capital

Target

YesWeHack

Paris, France
YesWeHack is a cybersecurity technique consisting of incentivizing a community of ethical hackers to detect and report vulnerabilities in exchange for bounties. YesWeHack was founded in 2015 and is based in Paris, France.

Search 199,442 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Wendel Group

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1704
Size Large
Type Sector Agnostic
DESCRIPTION

Wendel Group is a publicly traded investment group that seeks to invest €200 to €700 in public and private companies. The Firm focuses on opportunities across France, Germany, and the Benelux, but will also consider opportunities in greater Europe, North America, and select regions of Africa. Target companies typically exhibit predictable cash-flows, high barriers to entry, and are leaders in their respective markets. Wendel was originally established in 1704 and is based in Paris.


DEAL STATS #
Overall 25 of 25
Sector (Information Technology) 4 of 4
Type (Growth Capital) 7 of 7
Country (France) 10 of 10
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-12-01 Aqemia

Paris, France

Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, their pipeline scales the drug discovery process at an unprecedented pace, generating an exhaustive number of new drug candidates. Aqemia was founded in 2019 and is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-24 Preligens

Paris, France

Preligens develops pioneering technology to enhance operational decision-making to build a safer world. Its artificial intelligence solutions are based on an automated analysis of geospatial intelligence (GEOINT) workflows. Preligens was founded in 2016 and is based in Paris, France.

Sell €220M